Taxotere (docetaxel) is an injectable chemotherapy drug. Approved by the U.S. Food and Drug Administration (FDA) in 1996,1 Taxotere has been linked to permanent baldness.2 Chemotherapy patients who have a history of Taxotere use and who develop permanent hair loss may have a claim against the drug maker, Sanofi-Aventis (Sanofi).
The dangerous drug lawyers at the Amaro Law Firm have extensive experience helping injured people seek compensation and justice from negligent drug makers. Skilled at proving when medications cause harm, our attorneys can help you determine if you have a Taxotere claim – and, if so, help you strategically handle your claim.
Have You or a Loved One Experienced Permanent Hair Loss after Use of Taxotere?
Call (713) 352-7975, Text (281) 612-8024 or Email Our Firm
for Your FREE, No Obligations Case Evaluation
During your FREE consultation, we will explain your legal options, answer your questions, and advise you on how to move forward. Free virtual and mobile consultations are available to those who cannot visit our offices.
Chemotherapy Drug Taxotere: Background & Uses
Taxotere is FDA approved for the treatment of various types of cancer, including:
- Breast cancer
- Prostate cancer
- Stomach cancer
- Head cancer
- Neck cancer
- Some types of lung cancer.
Common, milder side effects of Taxotere, which typically go away when the use of the drug stops, can include (but are not limited to):
- Redness or inflammation at the injection site
- Nausea and/or vomiting
- Constipation or diarrhea
- Joint and/or muscle pain
- Changes to the fingernails or toenails.
Taxotere is often prescribed in combination with other chemotherapy drugs. The duration of Taxotere treatment will depend on the nature and severity of the cancer being treated.
Taxotere & Permanent Hair Loss (Alopecia)
Various studies conducted over the past decade or so have reported that Taxotere patients have a significant risk of developing permanent hair loss. Some of these studies include:
- A 2012 study, revealing that 10 to 15 percent of participants experienced irreversible baldness after use of Taxotere3
- A 2010 study, finding strong evidence of “an increasing number of reports of permanent alopecia chemotherapy-induced alopecia” with Taxotere as “the implicated agent”4
- A 2006 study, uncovering that more than 6 percent of participants with a history of using Taxotere experienced permanent hair loss.5
These and other studies have also found that:
- The irreversible alopecia caused by Taxotere more commonly impacts the scalp hair. It can also, however, affect hair on the face (such as eyebrow and eyelashes), as well as other body hair (including limb hair, armpit hair, etc.).
- Taxotere has a higher risk of permanent alopecia than other similarly effective chemotherapy drugs.
Up until 2015, warning labels on Taxotere in the U.S. only warned of the risk of temporary hair loss. In December 2015, the FDA updated its Taxotere warnings, indicating that “cases of permanent alopecia have been reported” by Taxotere patients.2
Other Serious Taxotere Side Effects
In addition to irreversible hair loss, Taxotere has also been linked to some other severe side effects, including (but not limited to):
- Severe, possibly life-threatening allergic reaction (anaphylaxis)
- Liver damage, including acute or chronic liver disease
- Dangerously low white blood cell counts.
Recovering from Severe Taxotere Side Effects: Taxotere Lawsuits & Multidistrict Litigation (MDL)
Patients who develop serious Taxotere side effects can experience adverse impacts like (but not limited to):
- Depression and/or anxiety
- Lower self-confidence
- Diminished quality of life.
Many patients who have developed severe and/or irreversible Taxotere side effects already taken action to file claims against Sanofi. Generally, Taxotere lawsuits allege that Sanofi:
- Failed to properly test the safety of Taxotere before bringing it to market
- Knew (or should have known) about the serious risks associated with Taxotere use
- Failed to warn physicians and the public about the serious risks linked to Taxotere.
Responding to the increasing number of Taxotere claims filed in state and federal courts, the Judicial Panel on Multidistrict Litigation (JPML) issued a transfer order in October 2016,6 consolidating many cases in an MDL based in the U.S. District Court, Eastern District of Louisiana (MDL No. 2740).
Newly filed Taxotere claims can join the still-pending MDL or be filed as individual claims. You can get answers about your best option for proceeding with a Taxotere claim by contacting an experienced Taxotere lawyer at the Amaro Law Firm.
Compensation for Taxotere Alopecia Claims
When Taxotere claims are successful, they can result in compensation for damages like (but not limited to):
- Medical care
- Lost wages and lost earning potential
- Permanent disfigurement
- Pain and suffering
- Punitive damages (in some cases).
Although awards for Taxotere claims can never reverse the impacts of permanent hair loss (or other serious Taxotere injuries), this compensation can be the key to pursuing treatment and rebuilding lives.
Find Out More About Your Potential Taxotere Claim: Contact a Dangerous Drug Lawyer at the Amaro Law Firm
A dangerous drug lawyer at the Amaro Law Firm is ready to review your potential Taxotere claim.
Call (713) 352-7975, text (281) 612-8024, or contact our firm for your FREE consultation and important answers about how to proceed. Taking this one step can pivotal to the strength and success of your claim, as well as your recovery and future.
The Amaro Law Firm’s record of extraordinary representation and success in dangerous drug claims has earned us exceptional testimonials from former clients, as well as 5-star ratings on Google and Facebook.
In Taxotere and other dangerous drug cases, we represent injured clients from across the U.S.
1: FDA approval & information for Taxotere
2: FDA warning about Taxotere & permanent hair loss
3: Study published in the Annals of Oncology (November 2012)
4: Study published in the Journal of the American Academy of Dermatology (August 2010)
5: Study conducted by Dr. Scot Sedlacek of the Rocky Mountain Cancer Centers
6: JPML Transfer Order establishing the Taxotere MDL
7: Taxotere MDL page